Display options
Share it on

J Natl Med Assoc. 1991 Sep;83(9):794-8.

End-stage renal disease and race: an overview and perspective.

Journal of the National Medical Association

R Ferguson

Affiliations

  1. Charles R. Drew University Hypertension Research Center, Los Angeles, California.

PMID: 1942113 PMCID: PMC2627098

Abstract

The epidemiology of end-stage renal disease (ESRD) in the United States is reviewed. Hypertension and diabetes as etiologic factors in ESRD in minorities are discussed, as is the question of a familial ESRD. It is hypothesized that diuretics as sole antihypertensive therapy in blacks may in the long term result in chronic volume contraction, increased sympathetic stimulation, and therefore, decreased renal function. As such, a rational basis for the long-term use of diuretics as the sole antihypertensive therapeutic in blacks becomes questionable at best.

Similar articles

References

  1. Am J Public Health. 1978 Feb;68(2):166-9 - PubMed
  2. Am J Public Health. 1987 Jul;77(7):864-5 - PubMed
  3. Am J Public Health. 1990 Jan;80(1):47-9 - PubMed
  4. Ann Intern Med. 1989 Nov 15;111(10):788-96 - PubMed
  5. N Engl J Med. 1989 Oct 19;321(16):1121-2 - PubMed
  6. N Engl J Med. 1989 Oct 19;321(16):1074-9 - PubMed
  7. Nephron. 1989;51(4):524-9 - PubMed
  8. Am J Kidney Dis. 1989 Jan;13(1):11-3 - PubMed
  9. J Clin Epidemiol. 1988;41(12):1189-96 - PubMed
  10. Am J Kidney Dis. 1988 Oct;12(4):285-90 - PubMed
  11. Am J Epidemiol. 1988 Jan;127(1):135-44 - PubMed
  12. Clin Exp Hypertens A. 1983;5(2):297-307 - PubMed
  13. Am J Public Health. 1984 Jan;74(1):14-7 - PubMed
  14. Health Care Financ Rev. 1984 Spring;5(3):69-88 - PubMed
  15. J Clin Invest. 1985 Aug;76(2):612-9 - PubMed
  16. Clin Nephrol. 1979 Feb;11(2):47-51 - PubMed

MeSH terms

Publication Types

LinkOut - more resources